user-generated· regulatory
FDA approves focused ultrasound for TTTS by Q4 2027
Market overview
The FDA grants 510(k) clearance for the Queen Charlotte's Hospital TTTS ultrasound treatment after Phase II trials confirm safety and efficacy in 80% of treated cases. Authorization would enable U.S. adoption starting in early 2028.
regulatory prediction market
- Implied probability (Yes)
- 60%
- Closes
- 2027-12-31
More regulatory markets
- UK government increases teacher pay offer by 2%+ in 2027 — 45% Yes
- FIFA issues formal disciplinary action against Trump by 2026-12-31 — 70% Yes
- UK government to allocate £200M for river clean-up by 2026 — 70% Yes
- FIFA issues formal reprimand against U.S. Soccer for Trump interference — 75% Yes
- Trump administration implements AI guardrails by Q4 2026 — 70% Yes
- Senate blocks OMB grant rule by December 2026 — 72% Yes
- Biden administration approves ICE detention project within 6 months — 40% Yes
- Forge Global secures Anthropic approval within 6 months — 75% Yes
Loading…